Patents by Inventor Keith M. Skubitz

Keith M. Skubitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040214184
    Abstract: The present invention relates to peptides capable of modulating the function (e.g., signaling or adhesive activities) of CD66 (CEACAM) family members and/or their ligands.
    Type: Application
    Filed: May 24, 2004
    Publication date: October 28, 2004
    Inventors: Keith M Skubitz, Amy P Skubitz
  • Patent number: 5545668
    Abstract: Glutamine is administered orally at a rate of about 4.5 g/m.sup.2 per day to treat oropharyngeal mucositis. This is administered to patients that experience or may develop oropharyngeal mucositis, especially those caused by chemotherapy or radiotherapy.
    Type: Grant
    Filed: November 17, 1994
    Date of Patent: August 13, 1996
    Inventors: Keith M. Skubitz, Peter M. Anderson
  • Patent number: 5438075
    Abstract: Glutamine is administered orally at a rate of about 4.5 g/m.sup.2 per day to treat oropharyngeal mucositis. This is administered to patients that experience or may develop oropharyngeal mucositis, especially those caused by chemotherapy or radiotherapy.
    Type: Grant
    Filed: March 30, 1993
    Date of Patent: August 1, 1995
    Inventors: Keith M. Skubitz, Peter M. Anderson
  • Patent number: RE39485
    Abstract: Glutamine is administered orally at a rate of about 4.5 g/m2 per day to treat oropharyngeal mucositis. This is administered to patients that experience or may develop oropharyngeal mucositis, especially those caused by chemotherapy or radiotherapy.
    Type: Grant
    Filed: May 18, 2004
    Date of Patent: February 6, 2007
    Assignee: Aesgen, Inc.
    Inventors: Keith M. Skubitz, Peter M. Anderson